Phone
Address
ZhengZhou (HQ), Shenzhen (R&D Center), Suzhou (R&D Center), China
Clinic Significance:
1. C-MET can be amplified in multiple tumors such as ovarian,breast,lung, thyroid, Gastric, pancreatic, colorectal and is an independent assessment factor of poor prognosis.
2. In non-small cell lung cancer, C-MET gene amplification was closely associated with poor prognosis and EGFR-TKIS resistance (seen in 11-22% of cases).
3.C-MET gene amplification is one of the targets of Crizotinib. In patients with C-MET gene amplification, tumor size can be significantly reduced after a period of treatment.
C-MET Normal
C-MET Amplification
Probe Description: C-MET/ Cep 7
Cat.No.: CF1013
Specification: 10 tests/box, 20 tests/box